Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a multidisciplinary process that uses explicit methods to determine a health technology’s value for healthcare decision-making. Attitudes towards HTA vary globally, with some countries using a variety of methods and analyses and others hardly any.
Changes in Determining Medicines Pricing in France, Germany and the UK
24 January 2013
New requirements for health technology assessment in Europe have important implications for markets and for access to new medicines. At a recent conference, OHE’s Jorge Mestre-Ferrandiz…
New Pilot Study: Capturing Public Preferences about Health Care Priorities
16 January 2013
The proposals from the UK Department of Health (DH) for value based pricing (VBP) include a process whereby higher prices would be granted to medicines that…
The Influence of Cost-effectiveness and Other Factors on NICE Decisions
1 November 2013
In this Research Paper, the authors explore which factors have most influenced NICE decisions from 1999 through the end of 2011. The research has two objectives:…
Spotlight on OHE: Making Health Care Choices and Decisions
7 January 2013
OHE’s research and consulting captures a range of key issues that affect how health care systems are organised and how decisions are made within them. For…
What constitutes credible evidence of effectiveness
1 June 2013
In this monograph based his remarks at the 19th OHE Annual Lecture, Professor Sir Michael Rawlins examines the standards of proof required to show the effectiveness…
Spotlight on OHE: Value Based Pricing and New Technologies
31 December 2012
The OHE has been very active in conceptualising approaches incorporating a broader assessment of the elements of value (often called “value based pricing” or “VBP”), as…
Spotlight on OHE: Measurement and Valuation of Health Using PROMs
20 December 2012
The OHE continues to play a central role in the development and use of patient-reported outcomes measures (PROMs). The last quarter of 2012 was characteristically busy.
New Research by OHE and University of Glasgow on cost of QALYs in Scotland
17 December 2012
New health care technologies often improve health but also increase costs. Judging whether they are good value for money involves comparing what QALYs are gained from…
New Findings: Public Attitudes Towards End-of-Life Treatment in England and Wales
7 December 2012
In 2009, the UK’s National Institute for Health and Clinical Excellence (NICE) issued supplementary advice that its Appraisal Committees are to consider when assessing treatments that…